Hair Loss From Medications: Which Drugs Cause Shedding (and What to Do About It)

If you started a new prescription a few months ago and your hair has just started shedding, the medication is a real candidate. Most cases reverse once the drug is stopped or switched, and most do not require stopping the drug at all.

What this article will not do is tell you to quit your blood pressure medication because of hair. The decision to continue, switch, or stop a medication belongs with the prescriber who knows your full picture. What it will do is give you the same map a dermatologist works from: which drug classes are well-documented causes of shedding, what the typical timeline looks like, and how to have a useful conversation with the prescriber instead of a panicked one.

How a drug causes hair to fall out

Drugs cause hair loss through one of two mechanisms, and they look very different¹ .

Telogen effluvium (TE) is the common one. The drug shifts a fraction of growing (anagen) follicles into the resting (telogen) phase prematurely. Those follicles all shed together two to four months later, when the telogen phase ends. The shedding is diffuse across the whole scalp, the shed hairs are full thickness with a small white club-shaped bulb at the root, and density typically returns to baseline once the drug is stopped or the body adjusts. We cover the underlying mechanism in detail in our telogen effluvium guide.

Anagen effluvium is the rare and dramatic one. Cytotoxic drugs, mostly chemotherapy, kill or arrest the rapidly-dividing cells of the hair matrix directly. Loss starts within 1 to 3 weeks of starting treatment, can affect 80 to 100 percent of scalp hair, and the shed hairs come out tapered or broken because they were damaged mid-growth. Unlike TE, you do not wait for a 2 to 4 month delay. Regrowth begins weeks after the chemotherapy course ends. This article focuses on the much more common telogen effluvium type; chemotherapy-related loss is a separate clinical conversation with an oncology team.

A small number of drugs (notably some hedgehog inhibitors used for advanced basal cell carcinoma, and the older interferon therapies) can cause permanent or scarring alopecia, but these are uncommon and the prescribing specialist will have flagged the risk¹ .

Which drugs are common culprits

The list of medications associated with hair loss is long; the list with strong evidence is shorter. The table below covers the classes most worth knowing about, with the type of shed, typical onset, and what to expect when the drug is stopped or substituted^{1 2} .

A few notes on the table. First, “associated with” does not mean “definitely caused by”. Many drugs are reported to cause hair loss in case series and pharmacovigilance databases, but the underlying biology has not always been confirmed in trials³ . The classes above are the ones with the most consistent reports.

Second, the reported frequency is usually low. For most of the cardiovascular drugs in the table, alopecia is listed as “rare” or “uncommon” in the prescribing information, meaning fewer than 1 in 100 patients report it. Isotretinoin is one of the better-quantified culprits: in a systematic review, hair loss was reported in 3.2 percent of patients on doses below 0.5 mg/kg/day and 5.7 percent on doses at or above that threshold⁴ .

Third, the 5α-reductase inhibitor “paradox shed” is real but distinct. Finasteride and dutasteride can cause a brief synchronised shed in the first 2 to 8 weeks of treatment, as follicles transition into a new growth cycle. It self-resolves, it is not a sign the drug is failing, and continuing through it is the standard advice. We cover this in detail in our finasteride vs. dutasteride guide.

How to tell if it really is the medication

Several patterns are consistent with a drug being the trigger:

• Timing. Diffuse shedding that started 2 to 4 months after beginning a new drug or after a dose change is the textbook pattern for drug-induced TE² .
• No other obvious cause. No recent illness, surgery, childbirth, severe stress, crash diet, or pregnancy. The drug becomes the leading suspect by elimination.
• The drug is on the list above. Common offenders (beta blockers, ACE inhibitors, isotretinoin, anticoagulants, lithium, certain antidepressants, hormonal changes) carry more weight than drugs without a documented signal.
• Diffuse, full-thickness shed across the whole scalp. Not a sharply-bordered patch (that suggests alopecia areata), and not a slow widening of the part over years (that suggests pattern hair loss).

Several patterns suggest the drug is not the cause, even if you started a new prescription recently:

• Loss is concentrated at the temples, crown, or central scalp in a familiar pattern. Drug-induced TE is diffuse; pattern loss is geographic.
• The shed has been going on for years, predating any of your current medications.
• You have systemic symptoms (period changes, fatigue, weight change, cold intolerance) that point at thyroid, anaemia, or iron deficiency. Bloodwork rules these in or out faster than blaming the drug. The high-yield panel is covered in our hair loss blood tests guide.
• There is a scalp problem (redness, scaling, pain, smooth shiny patches). Drug-induced TE has a normal scalp; visible scalp inflammation suggests a different category that needs a dermatologist.

What to do (and what not to do)

Do not stop the drug on your own. This is the single most important rule. Suddenly discontinuing beta blockers, antidepressants, anticonvulsants, anticoagulants, or many other drugs can cause genuine harm, including rebound hypertension, withdrawal symptoms, seizures, and clotting events. The cosmetic concern of hair loss is far outweighed by the medical risk of an unsupervised stop.

Have the conversation with the prescriber. Bring three things: when the shedding started, what you started or changed in the 2 to 4 months before that, and the broader context of the drug (is it preventing a dangerous event like stroke, or treating a non-life-threatening condition where alternatives exist?). The prescriber can usually answer one of:

1. Continue. The medication is treating something serious, the shedding is likely temporary, and waiting is the right call.
2. Switch within the class. Some drugs in a class are more associated with alopecia than others. Atenolol may shed when nadolol does not, for example.
3. Switch class. A different mechanism may be acceptable, depending on the indication.
4. Reduce the dose. Often relevant for isotretinoin (lower mg/kg/day reduces shedding rates) and for some psychiatric drugs.
5. Stop, with a taper if needed. Reasonable if the indication has resolved or alternatives are available.

Address the things that compound the problem. Drug-induced TE is worse on top of low ferritin, low vitamin D, sub-clinical thyroid dysfunction, restrictive eating, or a recent illness. Hair specialists target ferritin above 50 ng/mL for active hair loss, well above the typical lab “normal” cutoff of 15 to 30. Treating these does not stop the drug-induced shedding directly, but it removes the second hit.

Wait the timeline out, if you and the prescriber decide to continue. Most drug-induced TE peaks within 2 to 4 months of becoming visible and resolves within 3 to 6 months of stopping the trigger (or, with some drugs, of the body adjusting). Density typically returns to baseline. Photographic monitoring, monthly under the same lighting, gives a much better signal than the daily impression of “more in the brush than usual”.

No cosmetic intervention shortens the course meaningfully. No supplement, topical, laser device, or scalp treatment has been shown in randomised trials to accelerate recovery from drug-induced TE in well-nourished people. Topical minoxidil is sometimes used adjunctively if pattern hair loss is also present, but it is not the standard treatment for drug-induced shedding.

When the drug is not negotiable

Some drugs cannot be substituted. Antiretrovirals for HIV, anticoagulants after a deep vein thrombosis or atrial fibrillation, immunosuppressants after a transplant, anticonvulsants for seizure control: in many of these, the mortality consequences of stopping massively outweigh the cosmetic consequences of continuing.

In these cases, the realistic frame is:

• The shedding is almost certainly temporary, even on continued treatment, because the body often adapts after the initial 2 to 4 months.
• If the drug is required indefinitely, density usually plateaus rather than continuing to decline. People do not become bald from beta blockers.
• Coexisting reversible contributors (iron, thyroid, nutrition) are worth treating because they multiply the visible effect.
• The cosmetic interventions that work for pattern hair loss (minoxidil, finasteride for men) work on top of, not against, drug-induced shedding, so they remain options if pattern loss is also present.

When to see a dermatologist

A GP or prescriber is usually the right first call for “is this my medication?” A dermatologist becomes useful when:

• The shedding has not started to settle within 6 months of stopping or substituting the suspected drug
• You are not sure the drug is the cause and want a structured workup
• Bloodwork is normal and shedding continues
• There is also a scalp problem (redness, scaling, itching, scarring, or pain)
• A patch of complete loss has appeared, suggesting alopecia areata rather than drug-induced TE
• You are female with central thinning that pre-dates the drug and may be female pattern hair loss masked by, or coexisting with, a drug-induced shed
• The cosmetic impact is significant enough to warrant treatment for any underlying pattern loss

What this article does not cover

We have focused on commonly prescribed drugs that cause reversible shedding through telogen effluvium. We have only briefly mentioned chemotherapy-related anagen effluvium, which deserves its own dedicated coverage and should be discussed with the oncology team rather than self-managed. We have left out the rarer cases of permanent drug-induced alopecia (some hedgehog inhibitors, certain endocrine therapies in cancer treatment) which are usually flagged in advance by the prescribing specialist.

The list of “drugs reported to be associated with hair loss” in pharmacovigilance databases is enormous, and many associations are weak. The classes here are the ones with the most consistent reports across the literature. If you suspect a drug not on the table, the right move is the same: do not stop it on your own, raise it with the prescriber, and let them weigh the indication against the cosmetic effect.

Hair loss in the middle of taking a medication you genuinely need is exhausting because the trade-off feels unfair: the drug is doing important work, and the side effect is visible to everyone. The reassurance worth holding onto is that almost all drug-induced hair loss is temporary, and most of it does not require a hard choice between the drug and the hair. If it is affecting your wellbeing, talk to your GP or dermatologist. You are not making the connection up, and you are not alone in finding it hard.